Milbank represented JPMorgan Chase Bank, N.A. as the initial lender and issuing bank in connection with Healogics, LLC’s (“Healogics”) incurrence of a new $30 million revolving credit facility and a new $370 million first lien term loan. The financing resulted in an extension of Healogics' debt maturity schedule, with no significant maturities prior to 2025 and was part of an out-of-court restructuring transaction through which Healogics was able to recapitalize. Healogics also accepted $240 million in new equity investment to support future growth.
Based in Jacksonville, Florida, Healogics is the leading provider of advanced wound care in the United States with a network of nearly 600 Wound Care Centers® designed to care for people with hard-to-heal wounds. The new equity investment will allow Healogics to expand their reach and improve their operational capacity.
The Milbank Global Leveraged Finance team was led by New York-based partner Jerome McCluskey with associates Alexis Soshnick, George Miller, Mitch Cooper and Jacques Zelnik.
